Access cutting-edge idiopathic pulmonary fibrosis treatment through this clinical trial at a research site in The Woodlands. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this The Woodlands location
Preparing your pre-screening questions…
Access idiopathic pulmonary fibrosis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related idiopathic pulmonary fibrosis treatment provided free
Check if you qualify for this idiopathic pulmonary fibrosis clinical trial in The Woodlands, TX
No-Cost Study Care
Local to The Woodlands
Convenient for TX residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is open to adults with idiopathic pulmonary fibrosis (IPF) who are 40 years and older. The purpose of this study is to find out whether a medicine called pirfenidone changes the amount of a medicine called BI 1015550 in the blood. Some people may take more than one medicine at a time. Therefore, it is important to understand how different medicines influence one another. Participants take one dose of BI 1015550 as a tablet. Participants then take one tablet of pirfenidone 3 times a day for one week. The dose is then increased to 2 tablets 3 times a day for the second week. In the third week the dose is increased further to 3 tablets 3 times a day. Participants then take another dose of BI 1015550 as a tablet. Participants are in the study for a little over 1 month. During this time, they visit the study site 15 times. Two of the visits include overnight stays at the study site. The study staff also contacts the participants by phone. During the visits, the doctors collect information about participants' health and take blood samples from the participants. They compare the amount of pirfenidone and BI 1015550 in the blood. Doctors also regularly check participants' health and take note of any unwanted effects.
Sponsor: Boehringer Ingelheim
Yes, this clinical trial (NCT06241560) has an active research site in The Woodlands, TX that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for idiopathic pulmonary fibrosis treatment options in The Woodlands, TX, this clinical trial (NCT06241560) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our The Woodlands research site is actively enrolling participants for this clinical trial. You'll receive care from experienced idiopathic pulmonary fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all idiopathic pulmonary fibrosis clinical trials near you to find additional studies recruiting in your area.
See all pulmonary fibrosis clinical trials recruiting in The Woodlands — not just this study.
Browse Pulmonary Fibrosis Trials in The Woodlands →